Expert Talk
A Comprehensive Guide to Toxicology in Nonclinical Drug Development
I created this comprehensive guide on toxicology in nonclinical drug development to fill the market gap in resources
Deep Learning and the Future of Pulmonary Fibrosis Research
Deep learning imaging technology is being integrated into clinical trials to more deeply examine structures of the lung
Battling Drug Diversion and Counterfeiting
The Epidemic Plaguing the Pharmaceutical Industry
In recent years the global pharmaceutical supply chain has seen significant shifts From the rise of ecommerce
What’s Next for Cell and Gene Therapies?
There are many but to me two key areas stand out realtime analytics and potency control Todays tools still rely on
The Future of mRNA Technology in Vaccine and Drug Development
MRNA technology is expanding into multiple therapeutic areas Key applications include personalized cancer
Bridging the Gap Between Lab and Market
The failure of pharmaceutical RD breakthroughs to reach the market stems from multiple challenges Many drug candidates fail during latestage clinical trials due to insufficient efficacy or unexpected safety issues despite promising early results Regulatory requirements demand extensive proof of safety and effectiveness
Bridging the Gap: Why CMC Expertise is Key to Scaling Biotech and CDMO Solutions
CMC is at the heart of biopharmaceutical success yet it remains one of the most misunderstood aspects of drug development Many biotech firms particularly startups and midsized companies operate in a discoverydriven mindset focusing primarily on scientific innovation preclinical efficacy and securing investment While these aspects are undoubtedly im...
Data-driven Marketing Approaches
My journey in healthcare communications and marketing began at McCann Health in Mumbai about two decades ago
Balancing Innovation and Risk Management in R&D
Biotech companies and big pharma must leverage their complementary strengths to manage the risks of advancing innovative
Effective Management of the Development and Clinical Drug Supply in the Pharmaceutical Industry
The initial mapping of the value chain for clinical drug supply and which key elements to prioritize is dependent on the stage
